Trademark: 79208607
Word
E
Status Date
Tuesday, November 13, 2018
Registration Number
5603613
Registration Date
Tuesday, November 13, 2018
Filing Date
Thursday, December 15, 2016
Published for Opposition
Tuesday, August 28, 2018
5 Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
42 Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
The mark consists of patterns of dark and light green dots forming irregular circles, lines, and hexagons, all of which together form the letter "E"; several light green dots appear at random surrounding the "E". The color white represents the background, outlining, shading and/or transparent areas and is not part of the mark.
Green.
EVOX
The color(s) green is/are claimed as a feature of the mark.
Nov 13, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 4, 2021
New Representative At Ib Received
Jul 30, 2020
New Representative At Ib Received
Mar 8, 2019
Final Decision Transaction Processed By Ib
Feb 20, 2019
Final Disposition Notice Sent To Ib
Feb 20, 2019
Final Disposition Processed
Feb 13, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 13, 2018
Registered-Principal Register
Aug 28, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 28, 2018
Published For Opposition
Aug 24, 2018
Notification Processed By Ib
Aug 8, 2018
Notification Of Possible Opposition Sent To Ib
Aug 8, 2018
Notification Of Notice Of Publication E-Mailed
Aug 8, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 18, 2018
Approved For Pub - Principal Register
Jun 27, 2018
Teas/Email Correspondence Entered
Jun 27, 2018
Correspondence Received In Law Office
Jun 27, 2018
Teas Request For Reconsideration Received
Feb 15, 2018
Change Of Name/Address Rec'd From Ib
Jan 31, 2018
Attorney Review Completed
Jan 30, 2018
Correction From Ib Entered - Attorney Review Required
Jan 11, 2018
Notification Of Final Refusal Emailed
Jan 11, 2018
Final Refusal E-Mailed
Jan 11, 2018
Final Refusal Written
Dec 16, 2017
Teas/Email Correspondence Entered
Dec 15, 2017
Correspondence Received In Law Office
Dec 15, 2017
Teas Response To Office Action Received
Dec 15, 2017
Correction Transaction Received From Ib
Dec 13, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 13, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2017
Refusal Processed By Ib
Jun 17, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jun 17, 2017
Refusal Processed By Mpu
Jun 10, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jun 9, 2017
Non-Final Action Written
Jun 6, 2017
Application Filing Receipt Mailed
Jun 2, 2017
Assigned To Examiner
Jun 2, 2017
New Application Office Supplied Data Entered
Jun 1, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
